MedPath
FDA Approval

Tranexamic Acid

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
November 1, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Tranexamic acid(1 g in 10 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments2

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Emcure Pharmaceuticals Limited

Heritage Pharmaceuticals Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.

AVET LIFESCIENCES PRIVATE LIMITED

675467924

GLAND PHARMA LIMITED

Heritage Pharmaceuticals Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.

AVET LIFESCIENCES PRIVATE LIMITED

918601238

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tranexamic Acid

Product Details

NDC Product Code
23155-524
Application Number
ANDA203521
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
October 4, 2022
WATERInactive
Code: 059QF0KO0RClass: IACT
Code: 6T84R30KC1Class: ACTIBQuantity: 1 g in 10 mL
© Copyright 2025. All Rights Reserved by MedPath